Financial details of the transaction have not been disclosed but WEP said the deal created a ‘solid platform for future growth’.
UK-based Wren delivers a range of nursing services across a spectrum of therapy areas including oncology, haematology and rheumatology in patients’ homes. Its customers include the NHS and private hospitals and pharmaceutical companies in the UK and the rest of Europe.
Alongside at-home patient support for complex drug treatment and associated procedures, the company provides home nursing support for clinical trials, disease education and cross-therapy nursing support across clinical specialties.
Under the deal, it will be incorporated into the WEP team and gain access to the company’s patients, partners and customers.
Wren Healthcare Iain Campbell said: ‘Recent challenges within healthcare have highlighted the importance of clinical homecare. The Wren Healthcare team remain committed to providing evidence-based patient centric care that continues to positively impact those we support. WEP’s partnership, shared values, proven industry knowledge and experience further enhances the clinical services provided by Wren Healthcare. We look forward to future collaborations building a platform for growth and shared philosophy of helping patients lead healthier and more fulfilling lives.’
Jas Khera, WEP Clinical managing director added: ‘WEP and Wren’s shared philosophy of putting the patient and customer first make this new partnership a very exciting step forward for us at WEP. We look forward to providing these new services that will help patients lead healthier and more fulfilling lives.’